Home > News > Nanoparticles get a free ride
July 5th, 2007
Nanoparticles get a free ride
Abstract:
A breakthrough discovery in the US could see nanoparticles hitching a ride on red blood cells to become an ultimate drug delivery mechanism.
Nanoparticles have long been seen as a promising frontier for intravascular drug delivery but advances in the technology have been limited by the problem that nanoparticles are quickly removed from the blood rendering them ineffective in delivering drugs.
But researchers at the University of California, Santa Barbara, have found a solution to the problem - attaching nanoparticles to the surface of red blood cells (RBCs) dramatically increases the in vivo lifetime of the nanoparticles.
Source:
in-pharmatechnologist.com
| Related News Press |
Nanomedicine
New molecular technology targets tumors and simultaneously silences two ‘undruggable’ cancer genes August 8th, 2025
New imaging approach transforms study of bacterial biofilms August 8th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Discoveries
Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025
Next-generation quantum communication October 3rd, 2025
"Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025
Announcements
Rice membrane extracts lithium from brines with greater speed, less waste October 3rd, 2025
Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025
Next-generation quantum communication October 3rd, 2025
"Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025
|
|
||
|
|
||
| The latest news from around the world, FREE | ||
|
|
||
|
|
||
| Premium Products | ||
|
|
||
|
Only the news you want to read!
Learn More |
||
|
|
||
|
Full-service, expert consulting
Learn More |
||
|
|
||